![Frontiers | The mesenchymal compartment in myelodysplastic syndrome: Its role in the pathogenesis of the disorder and its therapeutic targeting Frontiers | The mesenchymal compartment in myelodysplastic syndrome: Its role in the pathogenesis of the disorder and its therapeutic targeting](https://www.frontiersin.org/files/Articles/1102495/fonc-13-1102495-HTML/image_m/fonc-13-1102495-g001.jpg)
Frontiers | The mesenchymal compartment in myelodysplastic syndrome: Its role in the pathogenesis of the disorder and its therapeutic targeting
Modeling the Structure of Amorphous MoS3: A Neutron Diffraction and Reverse Monte Carlo Study | Journal of the American Chemical Society
Discovery and Preclinical Pharmacology of a Selective ATP-Competitive Akt Inhibitor (GDC-0068) for the Treatment of Human Tumors | Journal of Medicinal Chemistry
![31MUYzyDUXL._CLa|557,500|31HJo5ZMALL.jpg,41yP3A-DGnL.jpg|0,0,253,500+304,0,253,500+126,0,304,500_._SY300_.jpg 31MUYzyDUXL._CLa|557,500|31HJo5ZMALL.jpg,41yP3A-DGnL.jpg|0,0,253,500+304,0,253,500+126,0,304,500_._SY300_.jpg](https://m.media-amazon.com/images/I/31MUYzyDUXL._CLa%7C557,500%7C31HJo5ZMALL.jpg,41yP3A-DGnL.jpg%7C0,0,253,500+304,0,253,500+126,0,304,500_._SY300_.jpg)